NEULAND LABORATORIES
Back to Balance Sheet
|
NEULAND LABORATORIES Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Deferred Tax Assets / Liabilities | ₹60 Cr | ₹58 Cr | ₹57 Cr | ₹60 Cr | ₹48 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of NEULAND LABORATORIES ?
Year | Deferred Tax Assets / Liabilities |
---|---|
Mar2024 | ₹60 Cr |
Mar2023 | ₹58 Cr |
Mar2022 | ₹57 Cr |
Mar2021 | ₹60 Cr |
Mar2020 | ₹48 Cr |
How is Deferred Tax Assets / Liabilities of NEULAND LABORATORIES Trending?
Years | Deferred Tax Assets / Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹60 Cr | 3.67 | |
Mar2023 | ₹58 Cr | 2.82 | |
Mar2022 | ₹57 Cr | -5.12 | |
Mar2021 | ₹60 Cr | 25.06 | |
Mar2020 | ₹48 Cr | - |
Compare Deferred Tax Assets / Liabilities of peers of NEULAND LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NEULAND LABORATORIES | ₹15,063.6 Cr | -19.8% | -13.8% | 90.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹409,003.0 Cr | -1.6% | -4.6% | 14.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹154,939.0 Cr | -1.6% | -1.3% | 61.6% | Stock Analytics | |
CIPLA | ₹117,835.0 Cr | 0.1% | 1.2% | 3.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹99,784.6 Cr | -2.1% | -8.7% | -2.3% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹90,722.1 Cr | -6.5% | -9.3% | 8.6% | Stock Analytics |
NEULAND LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NEULAND LABORATORIES | -19.8% |
-13.8% |
90.3% |
SENSEX | -2.5% |
-1.4% |
6.1% |
You may also like the below Video Courses